- CRS Publications
- News
News
Authors:
Date:
Business Wire: July 10, 2017 – STRASBOURG, France – Medical technology company Defymed, based in Strasbourg, is pleased to announce the development of ExOlin® , a new insulin delivery device. Targeted at persons suffering from diabetes (type 1 diabetics and some type 2 diabetics) needing to…
Authors:
Date:
Business Wire: July 5, 2017 – CLEVELAND, OH, U.S.A. – Diasome Pharmaceuticals, Inc., an innovative life sciences technology company focused on the development of novel therapies for the treatment of diabetes and other metabolic conditions, announced the agreement today of new funding of up to $30…
Authors:
Date:
Business Wire: June 26, 2017 – NEWARK, CA, U.S.A. – Icon Bioscience Inc. (IBI), a specialty biopharmaceutical company focused on utilizing its Verisome® drug-delivery platform to develop unique intraocular eye-care therapeutics, today announced that it has received notification from the U.S. Food…
Authors:
Date:
Business Wire: June 21, 2017 – SAN CLEMENTE, CA, U.S.A. – Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that a study…
Authors:
Date:
PRNewswire: June 21, 2017 – SASKATOON, SK, Canada, and CALGARY, AB, Canada – Potash Corporation of Saskatchewan Inc. (PotashCorp) (TSX and NYSE: POT) and Agrium Inc. (Agrium) (TSX and NYSE: AGU) announced today that once the anticipated merger transaction closes, the new company will be named…
Authors:
Date:
Business Wire: June 20, 2017 – DENVER, CO, U.S.A. – NanoSphere Health Sciences, LLC, developer of the innovative, industryfirst, patent-pending NanoSphere Delivery System™ for cannabis and other pharmaceuticals, today announces that it has signed a binding merger agreement with Corazon Gold Corp. (…
